Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.14365/5947
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBolek, H.-
dc.contributor.authorKuzu, O.F.-
dc.contributor.authorSertesen Camoz, E.-
dc.contributor.authorSim, S.-
dc.contributor.authorSekmek, S.-
dc.contributor.authorKarakas, H.-
dc.contributor.authorUrun, Y.-
dc.date.accessioned2025-02-25T19:32:13Z-
dc.date.available2025-02-25T19:32:13Z-
dc.date.issued2025-
dc.identifier.issn2523-3548-
dc.identifier.urihttps://doi.org/10.1002/cac2.70003-
dc.identifier.urihttps://hdl.handle.net/20.500.14365/5947-
dc.language.isoenen_US
dc.publisherJohn Wiley and Sons Incen_US
dc.relation.ispartofCancer Communicationsen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleSunitinib in Metastatic Renal Cell Carcinoma: Clinical Outcomes Across Risk Groups in a Turkish Oncology Group Kidney Cancer Consortiumen_US
dc.typeLetteren_US
dc.identifier.doi10.1002/cac2.70003-
dc.identifier.scopus2-s2.0-85217359773-
dc.departmentİzmir Ekonomi Üniversitesien_US
dc.authorscopusid57211652341-
dc.authorscopusid59150821900-
dc.authorscopusid59547302000-
dc.authorscopusid59481213500-
dc.authorscopusid57226085393-
dc.authorscopusid58716740900-
dc.authorscopusid57203683804-
dc.relation.publicationcategoryDiğeren_US
dc.identifier.scopusqualityQ1-
dc.identifier.wosqualityQ1-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
item.languageiso639-1en-
item.openairetypeLetter-
Appears in Collections:Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Show simple item record



CORE Recommender

Page view(s)

6
checked on Mar 10, 2025

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.